bioRxivCancer Biology
Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia
Simone EckeriD, Vera Pancaldi, Daniel RicoiD, Alfonso ValenciaiD
Abstract
BackgroundChronic Lymphocytic Leukemia (CLL) presents two subtypes which have drastically different clinical outcomes. So far, these two subtypes are not associated to clear differences in gene expression profiles. Interestingly, recent results have highlighted important roles for heterogeneity, both at the genetic and at the epigenetic level in CLL progression.\n\nResultsWe propose to use gene expression variability across patients to investigate differences between the two CLL subtypes. We find that the most aggressive type of this disease shows higher variability of gene expression across patients and we elaborate on this observation to produce a method that classifies patients into clinical subtypes. Finally, we find that, overall, genes that show higher variability in the aggressive subtype are related to cell cycle, development and inter-cellular communication, probably related to faster progression of this disease subtype.\n\nConclusionsThere are strong relations between disease subtype and gene expression variability linking significantly increased expression variability to phenotypes such as aggressiveness and resistance to therapy in CLL.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: cell type annotation
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia
Almut Luetge, Junyan Lu, … Thorsten Zenz·bioRxiv·Apr 16, 2021
- Data-driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes
M. Nourbakhsh, N. Tom, … E. Papaleo·bioRxiv·Feb 26, 2024
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients
Alastair Smith, Nicholas Denny, … Thomas A. Milne·BloodPeer-reviewed·Jul 29, 2025
- MYC overexpression drives poor prognosis and differential sensitivity to treatments according to TP53 status in chronic lymphocytic leukemia
Alba Garrote-de-Barros, Juan Pérez‐Fernández, … María Hernández‐Sánchez·bioRxiv·May 18, 2026
- Proliferating CLL cells express high levels of CXCR4 and CD5
D. Friedman, D. P. Mehtani, … R. Hoogeboom·bioRxiv·Dec 27, 2023
- Prediction of therapy outcomes of CLL using gene expression intensity, clustering, and ANN classification of single cell transcriptomes
Minjie Lyu, Huan Jin, … Vladimir Brusić·bioRxiv·Aug 8, 2021